Get the Stockscreener App
33.05
0.09%
-0.03
Enovis Corp stock is traded at $33.05, with a volume of 1.75M.
It is down -0.09% in the last 24 hours and down -3.42% over the past month.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
See More
Previous Close:
$33.08
Open:
$32.72
24h Volume:
1.75M
Relative Volume:
1.87
Market Cap:
$2.02B
Revenue:
$2.00B
Net Income/Loss:
$-119.19M
P/E Ratio:
-15.09
EPS:
-2.19
Net Cash Flow:
$-61.88M
1W Performance:
-6.37%
1M Performance:
-3.42%
6M Performance:
-28.80%
1Y Performance:
-35.26%
1-Day Range:
$32.19
$33.37
1-Week Range:
$30.65
$34.96
52-Week Range:
$29.32
$53.84
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
33.05 | 2.02B | 2.00B | -119.19M | -61.88M | -2.19 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-24 | Initiated | JP Morgan | Neutral |
| Feb-13-24 | Initiated | Stephens | Overweight |
| Jan-22-24 | Initiated | UBS | Buy |
| Jan-03-24 | Initiated | William Blair | Outperform |
| Dec-15-23 | Reiterated | Needham | Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Jun-26-23 | Initiated | Needham | Buy |
| May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-11-22 | Initiated | Goldman | Buy |
| Sep-12-22 | Initiated | Canaccord Genuity | Buy |
| Sep-12-22 | Initiated | Evercore ISI | Outperform |
| Jun-28-22 | Initiated | Argus | Hold |
| Jun-27-22 | Resumed | Loop Capital | Buy |
| Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
Enovis’ first-quarter net sales grow 8% to USD 559 million - Medical Buyer
Where Enovis Stands With Analysts - Benzinga
JMP Securities Adjusts Target Price for Enovis (ENOV) | ENOV Sto - GuruFocus
Enovis stock price target cut to $55 by JMP Securities - Investing.com Nigeria
Enovis (ENOV) Price Target Lowered by Needham Analyst | ENOV Sto - GuruFocus
Is Enovis (NYSE:ENOV) A Risky Investment? - simplywall.st
Enovis (ENOV) Price Target Lowered by Needham Analyst | ENOV Stock News - GuruFocus
Enovis (ENOV) Price Target Reduced by Citizens JMP Amid Positive Outlook | ENOV Stock News - GuruFocus
Enovis Q1 2025 slides: revenue beats expectations, profit guidance lowered on tariffs - Investing.com
Enovis Corp (ENOV) Q1 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Enovis Corp (ENOV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff Challenges - Yahoo Finance
Enovis Corporation Reports Strong Q1 2025 Growth - TipRanks
Decoding Enovis Corp (ENOV): A Strategic SWOT Insight - GuruFocus
Transcript : Enovis Corporation, Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com
Enovis CORP SEC 10-Q Report - TradingView
Enovis reports Q1 adjusted EPS 81c, consensus 74c - TipRanks
Earnings call transcript: Enovis Q1 2025 earnings beat expectations, stock drops - Investing.com Nigeria
Enovis: Q1 Earnings Snapshot - MySA
Enovis: Strong Q1 2025 Performance and Strategic Growth Justify Buy Rating - TipRanks
Enovis Q1 2025 slides: revenue beats expectations, profit guidance lowered on tariffs By Investing.com - Investing.com South Africa
Enovis stock down on reduced earnings forecast, $20M tariff impact - MassDevice
Enovis Q1 Adjusted Earnings, Sales Rise; Updates 2025 Outlook - marketscreener.com
Enovis (ENOV) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Enovis Corp Q1 2025 Earnings: Revenue Surpasses Estimates at $55 - GuruFocus
Enovis Corp Q1 2025 Earnings: Revenue Surpasses Estimates at $559M, EPS Misses with -$0.98 - GuruFocus
Enovis shares fall nearly 5% as Q1 revenue misses estimates, guidance disappoints - Investing.com Nigeria
Enovis earnings beat by $0.07, revenue fell short of estimates - Investing.com
ENOV Surpasses Q1 Revenue Projections with Robust Performance | ENOV Stock News - GuruFocus
Enovis Corporation Q1 2025 Financial Results - TradingView
Enovis Announces First Quarter 2025 Results - The Manila Times
Enovis (NYSE:ENOV) Posts Q1 Sales In Line With Estimates But Stock Drops - Yahoo Finance
Enovis Announces First Quarter 2025 Results | ENOV Stock News - GuruFocus
Earnings Flash (ENOV) ENOVIS CORPORATION Reports Q1 Adjusted EPS $0.81, vs. FactSet Est of $0.74 - marketscreener.com
Enovis Corporation Q1 2025 Earnings Preview - MSN
Enovis (ENOV) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
Enovis Corporation (ENOV): Among Billionaire Mason Hawkins’ Small-Cap Stocks with Huge Upside Potential - MSN
Orthopedic Appliances Market Set for Major Lucrative Growth US$ - openPR.com
Foot Innovate Welcomes Enovis™ Foot & Ankle as New Corporate Partner - Ortho Spine News
Enovis Corp to Host Q1 2025 Earnings Call and Webcast on May 8th - MSN
Are Options Traders Betting on a Big Move in Enovis (ENOV) Stock? - Nasdaq
Enovis Names Damien McDonald as New CEO to Drive Next Growth Chapter - MSN
Reasons to Sell ENOV and 1 Stock to Buy Instead - Yahoo Finance
Commit To Purchase Enovis At $25, Earn 10.7% Annualized Using Options - Nasdaq
Enovis to Host First Quarter 2025 Results Conference Call on May 8th - The Manila Times
Enovis to Host First Quarter 2025 Results Conference Call on May 8th | ENOV Stock News - GuruFocus
Enovis Corporation to Host Investor Conference Call for Q1 2025 Financial Results on May 8th - Nasdaq
Enovis Announces Third Quarter 2024 Results - ADVFN
Enovis’s Strategic Initiatives and Acquisitions Drive Buy Rating - TipRanks
Enovis names McDonald as CEO - MSN
Enovis appoints Damien McDonald as CEO - MedTech Dive
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):